Viewing Study NCT00010192


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2026-01-01 @ 6:59 PM
Study NCT ID: NCT00010192
Status: COMPLETED
Last Update Posted: 2013-06-06
First Post: 2001-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module